“Instead of spending on innovation, Big Pharma is hoarding its money for salaries and dividends,” the report says, “all while swallowing smaller companies, thus making the marketplace far less competitive.”
ADVISORY: The sale of Virutron® Pro Full Spectrum Antiviral + CES in One has resumed with newly updated NeuroSweep™ 2.0 waveforms! Thank you very much for your patience. Grab your own unit now before we run out of stocks again! Dismiss